{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:03:35Z","timestamp":1791259415992,"version":"4.1.0"},"reference-count":61,"publisher":"American Psychiatric Association Publishing","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2003,6,1]]},"DOI":"10.1176\/appi.ajp.160.6.1100","type":"journal-article","created":{"date-parts":[[2003,5,30]],"date-time":"2003-05-30T19:02:20Z","timestamp":1054321340000},"page":"1100-1109","source":"Crossref","is-referenced-by-count":95,"title":["Altered Transcript Expression of NMDA Receptor-Associated Postsynaptic Proteins in the Thalamus of Subjects With Schizophrenia"],"prefix":"10.1176","volume":"160","author":[{"given":"Sarah M.","family":"Clinton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahram","family":"Haroutunian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Meador-Woodruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1606BABDJGJE","doi-asserted-by":"crossref","unstructured":"Jones EG: Cortical development and thalamic pathology in schizophrenia. Schizophr Bull 1997; 23:483-501","DOI":"10.1093\/schbul\/23.3.483"},{"key":"R1606BABIAIHI","doi-asserted-by":"crossref","unstructured":"Andreasen NC, Paradiso S, O\u2019Leary DS: \u201cCognitive dysmetria\u201d as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr Bull 1998; 24:203-218","DOI":"10.1093\/oxfordjournals.schbul.a033321"},{"key":"R1606BABCEDJD","doi-asserted-by":"crossref","unstructured":"Andreasen NC, O\u2019Leary DS, Cizadlo T, Arndt S, Rezai K, Boles Ponto LL, Watkins GL, Hichwa RD: Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc Natl Acad Sci USA 1996; 93:9985-9990","DOI":"10.1073\/pnas.93.18.9985"},{"key":"R1606BABCAHCD","doi-asserted-by":"crossref","unstructured":"Andreasen NC, Arndt S, Swayze V II, Cizadlo T, Flaum M, O\u2019Leary D, Ehrhardt JC, Yuh WTC: Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 1994; 266:294-298","DOI":"10.1126\/science.7939669"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Buchsbaum MS, Someya T, Teng CY, Abel L, Chin S, Najafi A, Haier RJ, Wu J, Bunney WE Jr: PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry 1996; 153:191-199","DOI":"10.1176\/ajp.153.2.191"},{"key":"R1606BABHJIGC","doi-asserted-by":"crossref","unstructured":"Gilbert AR, Rosenberg DR, Harenski K, Spencer S, Sweeney JA, Keshavan MS: Thalamic volumes in patients with first-episode schizophrenia. Am J Psychiatry 2001; 158:618-624","DOI":"10.1176\/appi.ajp.158.4.618"},{"key":"R1606BABHIBEG","doi-asserted-by":"crossref","unstructured":"Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC: Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry 1998; 155:1711-1717","DOI":"10.1176\/ajp.155.12.1711"},{"key":"R1606BABIDGFI","doi-asserted-by":"crossref","unstructured":"Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT: Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992; 49:522-530","DOI":"10.1001\/archpsyc.1992.01820070016003"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Hazlett EA, Buchsbaum MS, Byne W, Wei T-C, Spiegel-Cohen J, Geneve C, Kinderlehrer R, Haznedar MM, Shihabuddin L, Siever LJ: Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. Am J Psychiatry 1999; 156:1190-1199","DOI":"10.1176\/ajp.156.8.1190"},{"key":"R1606BABGIAHE","doi-asserted-by":"crossref","unstructured":"Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S, Seaward J, McKenna P, Chua SE, Schnorr L, et al: A functional neuroanatomy of hallucinations in schizophrenia. Nature 1995; 378:176-179","DOI":"10.1038\/378176a0"},{"key":"R1606BABCIBIF","doi-asserted-by":"crossref","unstructured":"Byne W, Buchsbaum MS, Kemether E, Hazlett EA, Shinwari A, Mitropoulou V, Siever LJ: Magnetic resonance imaging of the thalamic mediodorsal nucleus and pulvinar in schizophrenia and schizotypal personality disorder. Arch Gen Psychiatry 2001; 58:133-140","DOI":"10.1001\/archpsyc.58.2.133"},{"key":"atypb3","doi-asserted-by":"crossref","unstructured":"Pakkenberg B: Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 1990; 47:1023-1028","DOI":"10.1001\/archpsyc.1990.01810230039007"},{"key":"R1606BABCHBHJ","doi-asserted-by":"crossref","unstructured":"Popken GJ, Bunney WE Jr, Potkin SG, Jones EG: Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc Natl Acad Sci USA 2000; 97:9276-9280","DOI":"10.1073\/pnas.150243397"},{"key":"R1606BABIDIBF","doi-asserted-by":"crossref","unstructured":"Danos P, Baumann B, Bernstein HG, Franz M, Stauch R, Northoff G, Krell D, Falkai P, Bogerts B: Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons. Psychiatry Res 1998; 82:1-10","DOI":"10.1016\/S0925-4927(97)00071-1"},{"key":"R1606BABFJIHI","doi-asserted-by":"crossref","unstructured":"Ibrahim HM, Hogg AJ Jr, Healy DJ, Haroutunian V, Davis KL, Meador-Woodruff JH: Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am J Psychiatry 2000; 157:1811-1823","DOI":"10.1176\/appi.ajp.157.11.1811"},{"key":"atypb4","doi-asserted-by":"crossref","unstructured":"Smith RE, Haroutunian V, Davis KL, Meador-Woodruff JH: Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Am J Psychiatry 2001; 158:1393-1399","DOI":"10.1176\/appi.ajp.158.9.1393"},{"key":"R1606BABIGHHJ","doi-asserted-by":"crossref","unstructured":"Smith RE, Haroutunian V, Davis KL, Meador-Woodruff JH: Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia. Neuroreport 2001; 12:2885-2887","DOI":"10.1097\/00001756-200109170-00026"},{"key":"R1606BABCGAHD","doi-asserted-by":"crossref","unstructured":"Popken GJ, Leggio MG, Bunney WE, Jones EG: Expression of mRNAs related to the GABAergic and glutamatergic neurotransmitter systems in the human thalamus: normal and schizophrenic. Thalamus & Related Systems 2002; 1:349-369","DOI":"10.1016\/S1472-9288(02)00008-0"},{"key":"R1606BABHAJDB","doi-asserted-by":"crossref","unstructured":"Meador-Woodruff JH, Healy DJ: Glutamate receptor expression in schizophrenic brain. Brain Res Brain Res Rev 2000; 31:288-294","DOI":"10.1016\/S0165-0173(99)00044-2"},{"key":"R1606BABBGBDC","doi-asserted-by":"crossref","unstructured":"Goff DC, Coyle JT: The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 2001; 158:1367-1377","DOI":"10.1176\/appi.ajp.158.9.1367"},{"key":"R1606BABGJICI","doi-asserted-by":"crossref","unstructured":"Lahti A, Holcomb H, Medoff D, Tamminga C: Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 1995; 6:869-872","DOI":"10.1097\/00001756-199504190-00011"},{"key":"R1606BABBIBDG","doi-asserted-by":"crossref","unstructured":"Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer JP: Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry 1994; 151:1234-1236","DOI":"10.1176\/ajp.151.8.1234"},{"key":"R1606BABFAIAD","doi-asserted-by":"crossref","unstructured":"Akbarian S, Sucher NJ, Bradley D, Tafazzoli A, Trinh D, Hetrick WP, Potkin SG, Sandman CA, Bunney WE Jr, Jones EG: Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci 1996; 16:19-30","DOI":"10.1523\/JNEUROSCI.16-01-00019.1996"},{"key":"R1606BABJBGEB","doi-asserted-by":"crossref","unstructured":"Dracheva S, Marras SAE, Elhakem SL, Kramer FR, Davis KL, Haroutunian V: N-Methyl-d-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am J Psychiatry 2001; 158:1400-1410; correction, 158:2107","DOI":"10.1176\/appi.ajp.158.9.1400"},{"key":"R1606BABCDCAI","doi-asserted-by":"crossref","unstructured":"Dean B, Scarr E, Bradbury R, Copolov D: Decreased hippocampal (CA3) NMDA receptors in schizophrenia. Synapse 1999; 32:67-69","DOI":"10.1002\/(SICI)1098-2396(199904)32:1<67::AID-SYN9>3.0.CO;2-Q"},{"key":"atypb5","doi-asserted-by":"crossref","unstructured":"Grimwood S, Slater P, Deakin JF, Hutson PH: NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia. Neuroreport 1999; 10:461-465","DOI":"10.1097\/00001756-199902250-00004"},{"key":"atypb6","doi-asserted-by":"crossref","unstructured":"Le Corre S, Harper CG, Lopez P, Ward P, Catts S: Increased levels of expression of an NMDARI splice variant in the superior temporal gyrus in schizophrenia. Neuroreport 2000; 11:983-986","DOI":"10.1097\/00001756-200004070-00017"},{"key":"R1606BABDHADA","doi-asserted-by":"crossref","unstructured":"Gao X-M, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA: Ionotropic glutamate receptors and expression of N-methyl-d-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiatry 2000; 157:1141-1149","DOI":"10.1176\/appi.ajp.157.7.1141"},{"key":"R1606BABCHFEF","doi-asserted-by":"crossref","unstructured":"Hollmann M, Heinemann S: Cloned glutamate receptors. Annu Rev Neurosci 1994; 17:31-108","DOI":"10.1146\/annurev.ne.17.030194.000335"},{"key":"R1606BABHFFFC","doi-asserted-by":"crossref","unstructured":"Das S, Sasaki YF, Rothe T, Premkumar LS, Takasu M, Crandall JE, Dikkes P, Conner DA, Rayudu PV, Cheung W, Chen HS, Lipton SA, Nakanishi N: Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 1998; 393:377-381","DOI":"10.1038\/30748"},{"key":"R1606BABBCBCC","doi-asserted-by":"crossref","unstructured":"Zukin R, Bennett M: Alternatively spliced isoforms of the NMDARI receptor subunit. Trends Neurosci 1995; 18:306-313","DOI":"10.1016\/0166-2236(95)93920-S"},{"key":"R1606BABJDCDE","doi-asserted-by":"crossref","unstructured":"Sheng M, Cummings J, Roldan L, Jan Y, Jan L: Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 1994; 368:144-147","DOI":"10.1038\/368144a0"},{"key":"R1606BABCJFAD","doi-asserted-by":"crossref","unstructured":"Tingley W, Roche K, Thompson A, Huganir R: Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain. Nature 1993; 364:70-73","DOI":"10.1038\/364070a0"},{"key":"R1606BABHIFDJ","doi-asserted-by":"crossref","unstructured":"Ehlers M, Zhang S, Bernhadt J, Huganir R: Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit. Cell 1996; 84:745-755","DOI":"10.1016\/S0092-8674(00)81052-1"},{"key":"R1606BABFBCBA","doi-asserted-by":"crossref","unstructured":"Brenman J, Christopherson K, Craven S, McGee A, Bredt D: Cloning and characterization of postsynaptic density 93, a nitric oxide synthase interacting protein. J Neurosci 1996; 16:7407-7415","DOI":"10.1523\/JNEUROSCI.16-23-07407.1996"},{"key":"R1606BABFAGEJ","doi-asserted-by":"crossref","unstructured":"Lau L, Mammen A, Ehlers M, Kindler S, Chung W, Garner C, Huganir R: Interaction of the N-methyl-d-aspartate receptor complex with a novel synapse-associated protein, SAP102. J Biol Chem 1996; 271:21622-21628","DOI":"10.1074\/jbc.271.35.21622"},{"key":"R1606BABJDGBC","doi-asserted-by":"crossref","unstructured":"Rutter A, Stephenson F: Coexpression of postsynaptic density-95 protein with NMDA receptors results in enhanced receptor expression together with a decreased sensitivity to L-glutamate. J Neurochem 2000; 75:2501-2510","DOI":"10.1046\/j.1471-4159.2000.0752501.x"},{"key":"R1606BABFDGGE","doi-asserted-by":"crossref","unstructured":"Sheng M, Pak D: Ligand-gated ion channel interactions with cytoskeletal and signaling proteins. Annu Rev Physiol 2000; 62:755-778","DOI":"10.1146\/annurev.physiol.62.1.755"},{"key":"R1606BABJAFGF","doi-asserted-by":"crossref","unstructured":"Ohnuma T, Kato H, Arai H, Faull R, McKenna P, Emson P: Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia. Neuroreport 2000; 11:3133-3137","DOI":"10.1097\/00001756-200009280-00019"},{"key":"R1606BABEBCCG","doi-asserted-by":"crossref","unstructured":"Clinton SM, Meador-Woodruff JH: Nucleus-specific expression of NMDA receptor-associated postsynaptic density proteins in primate thalamus. Thalamus & Related Systems 2002; 1:303-316","DOI":"10.1016\/S1472-9288(02)00004-3"},{"key":"R1606BABIIBBA","doi-asserted-by":"crossref","unstructured":"Meador-Woodruff JH, Mansour A, Bunzow JR, Van Tol HH, Watson SJ Jr, Civelli O: Distribution of D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci USA 1989; 86:7625-7628","DOI":"10.1073\/pnas.86.19.7625"},{"key":"R1606BABIHDHB","doi-asserted-by":"crossref","unstructured":"Miller JA: The calibration of 35S or 32P with 14C-labeled brain paste or 14C-plastic standards for quantitative autoradiography using LKB Ultrofilm or Amersham Hyperfilm. Neurosci Lett 1991; 121:211-214","DOI":"10.1016\/0304-3940(91)90687-O"},{"key":"R1606BABBIIFC","doi-asserted-by":"crossref","unstructured":"Standaert DG, Testa CM, Young AB, Penney JB Jr: Organization of N-methyl-d-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J Comp Neurol 1994; 343:1-16","DOI":"10.1002\/cne.903430102"},{"key":"atypb7","doi-asserted-by":"crossref","unstructured":"Meoni P, Bunnemann BH, Trist DG, Bowery NG: N-terminal splice variants of the NMDAR1 glutamate receptor subunit: differential expression in human and monkey brain. Neurosci Lett 1998; 249:45-48","DOI":"10.1016\/S0304-3940(98)00391-7"},{"key":"R1606BABFHCBA","doi-asserted-by":"crossref","unstructured":"Laurie DJ, Seeburg PH: Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA. J Neurosci 1994; 14(5, part 2):3180-3194","DOI":"10.1523\/JNEUROSCI.14-05-03180.1994"},{"key":"R1606BABDJDBI","doi-asserted-by":"crossref","unstructured":"Logan S, Rivera F, Leonard J: Protein kinase C modulation of recombinant NMDA receptor currents: roles for the C-terminal C1 exon and calcium ions. J Neurosci 1999; 19:974-986","DOI":"10.1523\/JNEUROSCI.19-03-00974.1999"},{"key":"R1606BABDIJJG","doi-asserted-by":"crossref","unstructured":"Zheng X, Zhang L, Wang AP, Bennett MV, Zukin RS: Protein kinase C potentiation of N-methyl-d-aspartate receptor activity is not mediated by phosphorylation of N-methyl-d-aspartate receptor subunits. Proc Natl Acad Sci USA 1999; 96:15262-15267","DOI":"10.1073\/pnas.96.26.15262"},{"key":"R1606BABECJHJ","doi-asserted-by":"crossref","unstructured":"Ehlers MD, Tingley WG, Huganir RL: Regulated subcellular distribution of the NR1 subunit of the NMDA receptor. Science 1995; 269:1734-1737","DOI":"10.1126\/science.7569904"},{"key":"R1606BABHFACH","doi-asserted-by":"crossref","unstructured":"Okabe S, Miwa A, Okado H: Alternative splicing of the C-terminal domain regulates cell surface expression of the NMDA receptor NR1 subunit. J Neurosci 1999; 19:7781-7792","DOI":"10.1523\/JNEUROSCI.19-18-07781.1999"},{"key":"R1606BABBFIBG","doi-asserted-by":"crossref","unstructured":"Standley S, Roche KW, McCallum J, Sans N, Wenthold RJ: PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants. Neuron 2000; 28:887-898","DOI":"10.1016\/S0896-6273(00)00161-6"},{"key":"R1606BABEGDAF","doi-asserted-by":"crossref","unstructured":"Scott DB, Blanpied TA, Swanson GT, Zhang C, Ehlers MD: An NMDA receptor ER retention signal regulated by phosphorylation and alternative splicing. J Neurosci 2001; 21:3063-3072","DOI":"10.1523\/JNEUROSCI.21-09-03063.2001"},{"key":"R1606BABJJBFD","doi-asserted-by":"crossref","unstructured":"Migaud M, Charlesworth P, Dempster M, Webster LC, Watabe AM, Makhinson M, He Y, Ramsay MF, Morris RG, Morrison JH, O\u2019Dell TJ, Grant SG: Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature 1998; 396:433-439","DOI":"10.1038\/24790"},{"key":"R1606BABICFBE","doi-asserted-by":"crossref","unstructured":"Ehlers M, Fung E, O\u2019Brien R, Huganir R: Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments. J Neurosci 1998; 18:720-730","DOI":"10.1523\/JNEUROSCI.18-02-00720.1998"},{"key":"R1606BABHFGFH","doi-asserted-by":"crossref","unstructured":"Lin J, Wyszynski M, Madhavan R, Sealock R, Kim J, Sheng M: Yotiao, a novel protein of neuromuscular junction and brain that interacts with specific splice variants of NMDA receptor subunit NR1. J Neurosci 1998; 18:2017-2027","DOI":"10.1523\/JNEUROSCI.18-06-02017.1998"},{"key":"R1606BABJEGAA","doi-asserted-by":"crossref","unstructured":"Xu Z, Dong DL, Cleveland DW: Neuronal intermediate filaments: new progress on an old subject. Curr Opin Neurobiol 1994; 4:655-661","DOI":"10.1016\/0959-4388(94)90006-X"},{"key":"R1606BABDHBDF","doi-asserted-by":"crossref","unstructured":"Shenolikar S: Protein serine\/threonine phosphatases\u2014new avenues for cell regulation. Annu Rev Cell Biol 1994; 10:55-86","DOI":"10.1146\/annurev.cb.10.110194.000415"},{"key":"R1606BABHCJJJ","doi-asserted-by":"crossref","unstructured":"Terry-Lorenzo R, Inoue M, Connor J, Haystead T, Armbruster B, Gupta R, Oliver C, Shenolikar S: Neurofilament-L is a protein phosphatase-1-binding protein associated with neuronal plasma membrane and post-synaptic density. J Biol Chem 2000; 275:2439-2446","DOI":"10.1074\/jbc.275.4.2439"},{"key":"R1606BABBCGJA","doi-asserted-by":"crossref","unstructured":"Cohen BM, Wan W: The thalamus as a site of action of antipsychotic drugs. Am J Psychiatry 1996; 153:104-106","DOI":"10.1176\/ajp.153.1.104"},{"key":"atypb8","doi-asserted-by":"crossref","unstructured":"Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA: Functional sites of neuroleptic drug action in the human brain: PET\/FDG studies with and without haloperidol. Am J Psychiatry 1996; 153:41-49","DOI":"10.1176\/ajp.153.1.41"},{"key":"R1606BABEAGIC","doi-asserted-by":"crossref","unstructured":"Deutch A, Ongur D, Duman R: Antipsychotic drugs induce Fos protein in the thalamic paraventricular nucleus: a novel antipsychotic drug action. Neuroscience 1995; 66:337-346","DOI":"10.1016\/0306-4522(94)00571-L"},{"key":"R1606BABCABAD","doi-asserted-by":"crossref","unstructured":"Ulas J, Nguyen L, Cotman C: Chronic haloperidol treatment enhances binding to NMDA receptors in rat cortex. Neuroreport 1993; 4:1049-1051","DOI":"10.1097\/00001756-199308000-00014"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.160.6.1100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T09:54:37Z","timestamp":1722419677000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.160.6.1100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,1]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,6,1]]}},"alternative-id":["10.1176\/appi.ajp.160.6.1100"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.160.6.1100","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,1]]}}}